Detalhe da pesquisa
1.
In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
Gastroenterology
; 159(6): 2163-2180.e6, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32814111
2.
Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer.
Nat Commun
; 14(1): 4677, 2023 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37542037
3.
The cholesterol uptake regulator PCSK9 promotes and is a therapeutic target in APC/KRAS-mutant colorectal cancer.
Nat Commun
; 13(1): 3971, 2022 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35803966